P
Peter G. Gibson
Researcher at University of Newcastle
Publications - 774
Citations - 53254
Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
Long‐acting beta2‐agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
TL;DR: There were significant advantages to LABA treatment compared to placebo for a variety of measurements of airway calibre including morning peak expiratory flow (PEF), evening PEF and FEV1, and there are potential safety issues which call into question the safety of LABA, particularly in those asthmatics who are not taking ICS.
Journal ArticleDOI
Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia.
TL;DR: In this article, a significant load of potentially pathogenic bacteria (> 10(6) cfu/mL) was cultured from the sputum of 17 (15%) subjects with stable asthma and was associated with higher total cell counts, proportion and number of neutrophils.
Journal ArticleDOI
Role of atypical bacterial infection of the lung in predisposition/protection of asthma.
TL;DR: A hypothesis of the effects of these infections on the development and prevention of asthma and how novel preventative and treatment strategies involving these microbes may be targeted against asthma is put forward.
Journal ArticleDOI
Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases
Lisa Wood,Manohar L. Garg,Jodie L. Simpson,Trevor A. Mori,Kevin D. Croft,Peter A. B. Wark,Peter G. Gibson +6 more
TL;DR: Examination of oxidative stress in airway disease according to disease type, disease activity, and disease pattern concludes that 8-iso-PGF(2alpha) is involved in the pathophysiology of inflammatory airway diseases, being related to diseasetype, pattern, and activity.